1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm: new trials by email Literature Review of Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm trials Research Report on Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm Carbon C 11 Alpha-methyltryptophan, Laboratory Biomarker Analysis, Positron Emission Tomography - Carcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm | Phase 2 | Completed | Barbara Ann Karmanos Cancer Institute | 4 | 2018-06-20 | 2025-04-10 |
Chemically-Induced Disorders (1) · Drug-Related Side Effects and Adverse Reactions (1)
Magnetic Resonance Spectroscopy (1) · alpha-methyltryptophan (1) · telotristat (1) · telotristat ethyl (1)
Barbara Ann Karmanos Cancer Institute (1)
United States (1)
Anthony Shields (1)
P30CA022453 (1)